NCT06929546View on ClinicalTrials.gov

Anti-phospolipid Antibodies in Lyme Borreliosis

Not yet recruitingOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

May 15, 2026

Study Completion Date

July 15, 2026

Conditions
Patients With Different Manifestations of Lyme BorreliosisPersons With Nonspecific Symptoms and Positive Borrelia Antibodies in SerumBlood Donors
Interventions
DIAGNOSTIC_TEST

Anti-phospholipid antibodies

Serum samples will be obtained for determination of IgG and IgM isotypes of 4 anti-phospholipid antibodies including anti-cardiolipin (aCL), anti-phosphatidylserine (aPS), anti-phosphatidic acid (aPA) and anti-phosphatidylcholine (aPC) with in-house ELISAs.

Trial Locations (1)

1525

University Medical Center Ljubljana, Ljubljana

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER